Molecular Mechanism of Nasopharyngeal Carcinoma
NCT00155181 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2005-09-12
Summary
EBV, infection process, immortalization, B lymphocytes, Epithelial cells, co-culture Epstein-Barr virus (EBV) belongs to human γ-herpes viruses. Unlike other human herpes viruses, EBV can only predominately infect two types of human cells: lymphoid cells and epithelial cells and its infection is associated with several human malignancies of these two cell types. The lymphoid cancers associated with EBV infection include Burkitt's lymphoma, Hodgkin's disease, B lymphoma in immunodeficient patients and T/NK cell lymphoma. The carcinomas associated with EBV are nasopharyngeal carcinoma and gastric carcinoma. One unique biological feature of EBV is that it can infect and immortalize primary B lymphocytes in vitro into lymphoblastoid cell lines (LCL). So far, limited information is known about the whole EBV infection process and its regulation mechanism for immortalization. In this project, three EBV infection models are setting up to reveal the cellular events and signal transduction pathway possibly involved in EBV infection process and immortalization course of action.
Conditions
- Nasopharyngeal Carcinoma
Sponsors & Collaborators
-
National Health Research Institutes, Taiwan
collaborator OTHER -
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Ching-Hwa Tsai, Ph D · National Taiwan University College of Medicine
Eligibility
- Min Age
- 30 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-01-31
- Completion
- 2005-08-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas
NCT06870435 ·Status: RECRUITING ·Phase: NA
-
Comparison of the Human Papillomavirus (HPV) Type 16 E7-Specific Immune Response Between a Normal Population and Patients With Cervical Lesions
NCT00154583 ·Status: UNKNOWN
-
Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)
NCT02045186 ·Status: TERMINATED ·Phase: NA
-
Diagnostic Accuracy of EBV C Promoter Methylation Kit in Nasopharyngeal Carcinoma
NCT06445088 ·Status: RECRUITING
-
Characterization of Immunosuppressive Signing of Cervical Cancer
NCT02875990 ·Status: UNKNOWN ·Phase: NA
-
e- Ab Sensor-based Real-time Detection of Oncogenic Human Papilloma Viruses
NCT01387997 ·Status: UNKNOWN ·Phase: NA
-
Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus
NCT05918510 ·Status: RECRUITING
-
Construction and Validation of a Diagnostic Model for Predicting Molecular Residual Disease and Recurrence of Cervical Cancer Based on Circulating Tumor HPV
NCT06456112 ·Status: NOT_YET_RECRUITING
-
Verification of Harmonization of Plasma Epstein-Barr Virus DNA Measurements
NCT05037357 ·Status: UNKNOWN
-
Multiple Human Papillomavirus Infections in the Development of CIN
NCT06862102 ·Status: RECRUITING
-
The Correlation Between the Haplotype of Human Leukocyte Antigen (HLA) and Human Papillomavirus
NCT00154479 ·Status: UNKNOWN
-
Discovery of HPV T Cell Epitopes and Development of Multi-epitope Vaccines
NCT07077980 ·Status: NOT_YET_RECRUITING
-
Negative HPV Test Results on Infinity/GeneXpert® With the Presence of a Late Amplification Signal: What Does This Mean ? (PaPCR)
NCT06919627 ·Status: COMPLETED
-
Epstein-Barr Detection in Oral Cancer
NCT01039272 ·Status: COMPLETED
-
HR-HPV Multi-site Opportunistic Screening in Liaoning, China
NCT03178136 ·Status: UNKNOWN
-
CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas
NCT02981862 ·Status: COMPLETED ·Phase: NA
-
Improving Detection and Early Action for HPV-positive Oropharynx Cancer
NCT04871490 ·Status: COMPLETED ·Phase: NA
-
Identifying Biomarkers for Early Detection of Cancer in Patients With Cervical Dysplasia or Carcinoma in Situ of the Cervix
NCT00601601 ·Status: COMPLETED
-
ctDNA Liquid Biopsy for Early Assessment of Residual Disease in HPV-associated Head and Neck Cancer (Clear-HPVca)
NCT06730412 ·Status: COMPLETED
-
Cyclooxygenase-2 Expression in Tissue Samples From Patients With a Normal Cervix, Cervical Intraepithelial Neoplasia, or Early Invasive Cervical Cancer
NCT00900081 ·Status: WITHDRAWN
-
Incidence of Cervical Cancer in HPV-positive Women With Low-grade Cytological Abnormalities
NCT07259616 ·Status: COMPLETED
-
Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 (CIN1) Persistence
NCT00682552 ·Status: TERMINATED ·Phase: NA
-
A Multi-center Survey of HPV in Cervical Intraepithelial Neoplasia (CIN) With Longitudinal Follow-up of LSIL Cases
NCT00201370 ·Status: COMPLETED
-
Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
NCT05774561 ·Status: RECRUITING
-
Comparison of Human Papillomavirus Integrated DNA and Messenger RNA in Cervical Neoplasia
NCT02198365 ·Status: COMPLETED